An Overview Of Thyroxine Drug And Its Application

This research paper provides a comprehensive pharmacovigilance assessment of levothyroxine, marketed as Thyroxine, a widely prescribed medication for thyroid disorders. The study aims to analyze adverse drug reaction (ADR) reports associated with levothyroxine, focusing on data collection, interpretation, and identification of its safety profile. Through a systematic analysis of pharmacovigilance data, common adverse reactions related to levothyroxine use will be identified, and the overall safety profile will be assessed, considering the severity and frequency of reported adverse events. The research will explore potential risks associated with levothyroxine use and evaluate the benefit-risk ratio in diverse patient populations. The findings aim to contribute valuable insights to healthcare professionals, regulatory agencies, and patients, facilitating informed decisions about levothyroxine use and enhancing ongoing safety monitoring efforts. This research also seeks to identify areas for further investigation, contributing to the continual improvement of patient care in the context of thyroid disorders.